Navigation Links
Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
Date:11/24/2009

SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) is scheduled to present at the 21st Annual Piper Jaffray Health Care Conference at The New York Palace in New York City on December 1, 2009 at 1:00 p.m. Eastern Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO)

A live audio webcast of this presentation will be accessible on the Investors page of the Company's website at www.optimerpharma.com. Replays of this presentation will be available at the same location for 30 days following the meeting.

About Optimer Pharmaceuticals

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin, formerly known as OPT-80, is the only antibiotic therapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Pruvel(TM) (prulifloxacin) is an antibiotic which has completed two Phase 3 clinical trials for the treatment of infectious diarrhea in travelers. Additional information can be found at http://www.optimerpharma.com.

    Contacts

    Optimer Pharmaceuticals, Inc.
    Christina Donaghy, Corporate Communications Manager
    John D. Prunty, Chief Financial Officer & VP Finance
    858-909-0736

    Porter Novelli Li
'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 The Parenteral Drug Association ... global post-approval changes protocols. The new ... topic expressed by industry participants and regulatory authority representatives ... month in Washington, DC . Representatives ... hand for the workshop. Attendees indicated openness to engaging ...
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
Breaking Medicine Technology:PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... in ... developing countries, SEATTLE, Jan. 22 ... has joined the Global Health,Program as director of Global Health Delivery. ... medical and public health,efforts, including preparations for a potential influenza pandemic., ...
... Diagnostic Application of Research Technologies, FULLERTON, Calif., ... ) announced today that it has signed four ... to direct assay,research and acquire licenses for intellectual ... for the company,s future molecular,diagnostic instrument. Under the ...
Cached Medicine Technology:Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 3
(Date:9/21/2014)... An experienced review website in the global market, ... and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and ... There has been a boom in websites in recent ... increase in the number of web hosting companies that ... prices. VPS (Virtual Private Server) is the method of ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Developers and ... have announced a new transition plugin entitled Transpack ... 3 delivers high quality transitions that will add a ... Christina Austin, CEO of Pixel Film Studios. “Blurring the ... a definite game changer.” , Transpack Vol. 3 returns ...
(Date:9/21/2014)... 2014 According to latest National Vital ... rate since 1966 (10.5 births per 1,000 women in 2013). ... has risen steadily by 2 percent per year. The birth ... aged 50 and over) also rose, the first such increase ... than nine times as many first births to women aged ...
(Date:9/20/2014)... UWDress.com, a professional company of women’s dresses and related ... evening cocktail dresses . As a matter of ... very popular among worldwide customers. Now, all its evening ... 65 percent off). , All UWDress.com’s employees are ... for the global clients. The company is famous for ...
(Date:9/20/2014)... 6 Minutes to Skinny , a ... Ballantyne that is showing men and women of all ages ... body fat using simple 6-minute exercises and easy-to-follow lifestyle tips ... investigative review. , “When it comes to losing body ... out for all people,” reports Michaels. “Metabolism plays a big ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2
... showing signs of changes that could lead to full-blown ... today's "baked potato generation"// could be falling prey to ... ,It has been recognised for some time that being ... of diabetes, but authentication is growing that younger patients ...
... take as much care of your hair as you do of ... that the outer layer of the hair - the cuticle - ... dry and faded.// Hair damage occurs from a range of causes ... exposure. Ideally, you'd pay as much attention to your hair as ...
... specific toxin can cause a severe, highly lethal type ... They have so far linked infection with these toxin-carrying ... tissue destruction in the respiratory tract. ,According ... of the National Reference Center for Staphylococcal Toxemia in ...
... treat both major strains of influenza in young children said ... flu season because production problems delayed its distribution. The medication, ... season. Hoffmann-La Roche informed the FDA of its production problems, ... required to do so. // ,Tamiflu is one of ...
... be suffering from anxiety or depression. According to a ... before aggressive treatments are begun// for gastrointestinal disorders. This ... harmful medications for nausea, unnecessary medical investigation and probably ... ,Haug and colleagues in the department of psychiatry conducted ...
... folic acid intake and decreasing alcohol help beat the risk ... to previous studies have shown that colon cancer often runs ... the disease, you can opt for regular colon exams, cut ... vegetables to reduce your cancer risk. ,According to ...
Cached Medicine News:Health News:Toxin connected to 'Flesh-eating' Pneumonia in Kids 2
Alexander periosteal elevators....
Lambotte periosteal elevators....
Cottle periosteal & skin elevator, 7 1/2", slightly curved blade, 9 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: